Hanbang Technology's IPO has been approved by the Shanghai Stock Exchange, with chromatography technology as its core competency.

On February 21, Hanbang Technology Co., Ltd. (hereinafter referred to as "Hanbang Technology") passed the IPO meeting of the Shanghai Stock Exchange's Science and Technology Innovation Board. The sponsor is CITIC Securities and the planned financing is RMB598 million.The prospectus reveals that Hanbang Technology is a high-tech enterprise integrating R&D, production and sales, with chromatography technology as its core, dedicated to "purifying chromatography technology and contributing to human health", and striving to "establish the first brand in the international chromatography industry". It mainly provides professional separation and purification equipment, consumables, application technical services and related technical solutions for the pharmaceutical, life sciences and other fields.The company's funds raised from this issue will be invested in the production of 1,000 units of liquid chromatography series separation equipment, the chromatography separation equipment R&D center project, and the production of 2,000 units (sets) of laboratory chromatography separation and purification instruments, which will help the company increase its R&D investment, expand its production scale, and continuously enhance the core product's competitive advantage, realizing its long-term healthy development. In recent years, Hanbang Technology has relied on its comprehensive product layout and leading customer service capabilities to respond to downstream market demand for various equipment products in a timely manner and actively expand overseas markets, forming a drug separation and purification equipment product with industry competitiveness.In terms of finance, Hanbang Technology achieved revenue of approximately RMB321 million, RMB482 million, RMB619 million and RMB329 million in 2021, 2022, 2023 and 1-6 months of 2024, respectively. During the same period, the Company achieved a net profit of approximately RMB4.8617 million, RMB38.5596 million, RMB51.4975 million and RMB37.6849 million, respectively.